Kunming Pharmaceutical Commercial

KPC Pharmaceuticals is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of plant-based medicines, particularly those derived from traditional Chinese medicine. The company is globally recognized as a major producer of artemisinin-based antimalarial drugs and is a pioneer in the industrialization of Panax notoginseng for cardiovascular health. KPC operates a comprehensive value chain including R&D, manufacturing, and a large-scale commercial distribution network. Recently integrated into the China Resources (CR) Sanjiu group, KPC continues to focus on core therapeutic areas such as cardiovascular diseases, cerebrovascular diseases, and chronic disease management.